Nevertheless, there are signs that the wave of CM's popularity has reached its peak. The ' (A Products and Environment that the maximum daily dose of vitamin B6 in supplements should be limited to 10 mg/day, the Royal Pharmaceutical Society advised its members to treat all products that exceed this limit as 'pharmacy-only' medicines13. Also in the UK, 60 of 314 supplements were accompanied by illegal claims for health benefit, and the Food Commission is calling for prosecution of those who flout the regulations14. All these measures would have considerable impact on sales.
Recently, the Lewisham Health Trust, London, discontinued its referrals to homoeopathic hospitals15. This decision was based on the argument that homoeopathy has not been convincingly shown to be effective. Several complementary therapy centres in London are closing down or are threatened with closure as a result of cuts in health authority funding16. In December 1995, a widely advertised British Medical Association conference on CM had to be called off because of lack of interest17. Our own department's courses, aimed at familiarizing general practitioners and other healthcare professionals with CM, suffer chronically from underbooking and I hear this is true of similar courses throughout Britain.
Probably the most influential article about the worldwide boom in CM was that by Eisenberg and colleagues in the New England Journal of Medicine five years ago. They reported that one-third of the US population was using CM in some form6. A more recent and perhaps more representative survey by Paramore18 (larger sample size) suggested that less than 10% do so. One reason for the discrepancy could be that Eisenberg et al. included treatments such as exercise which most of us would regard as mainstream, whilst Paramore focused on four defined CM treatment modalities; however, even the comparison of prevalence rates of specific treatments (e.g. chiropractic) yields striking differences in these two surveys. Could it be that the often cited popularity of CM was an overestimate in the first place?
In Europe, where legislation on CM differs greatly from country to country, a long-planned initiative for harmonization has lately been overruled. The European Parliament resisted the proposal aimed at unifying rules on training and qualifications for practitioners and instead demanded that current national systems should be studied and essential gaps in research be filled first19.
Collectively these diverse lines of evidence might suggest that the rise of CM is being succeeded by a decline. If this turns out to be true, some may celebrate the end of 0 E-14 'the flight from reason'. Others will lament that potentially helpful treatments will become less accessible. Yet both arguments fail to recognize a more fundamental issue. The efficacy and safety of CM are grossly underresearched20. Yet rigorous research should be welcomed by all parties.
Proponents would hope to demonstrate the true value of their treatments. Opponents would look forward to proving that CM is of no real benefit. Purchasers of healthcare would want to know what they are paying for (or thinking of paying for) and whether part of CM is worthy of integration into routine health care. Without proper research into CM, history is bound to repeat itself, and waves of popularity and disenchantment could follow each other in endless succession. This perpetual rise and fall of CM is scientifically unproductive and financially wasteful21'22. Most importantly, it is not in the best interest of our patients. The way forward, it seems, is neither enthusiastic promotion by believers nor continuous attacks by disbelievers. The way ahead can only be paved by good and unbiased research establishing whether and for which conditions the application of a given complementary therapy offers more net benefit than other treatments. To do this research we need neither believers nor disbelievers but objectivity, expertise, time, and money. 
